Notice of Informational Webinar on the NIGMS Technology Development Funding Opportunity Announcements (R21 and R01)

Notice Number: NOT-GM-19-040

Key Dates
Release Date: May 1, 2019

Related Announcements

Issued by
National Institute of General Medical Sciences (NIGMS)


The purpose of this Notice is to inform potential applicants to the NIGMS Technology Development R21 (PAR-19-254) and R01 (PAR-19-253) funding opportunity announcements (FOAs) of an upcoming webinar on planning submissions to this program. Participation in the webinar, although encouraged, is optional and is not required for application submission.


The NIGMS technology development FOAs support two stages of technology development: Stage 1 from concept to proof of concept (R21) and Stage 2 from feasibility to working prototype (R01).

The technology development FOAs encourage evaluation of technological hypotheses without the pressure to additionally test unknown biological questions. Technologies might originate from biomedical disciplines or from engineering and the physical sciences. Examples include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. Applications submitted to these FOAs that include untested biological hypotheses will not be funded. Validation studies are appropriate for these FOAs, and descriptions of the future biological utility to research within the mission of NIGMS are strongly recommended.

Webinar Information

During this webinar, NIGMS staff will discuss areas of science within the NIGMS mission, the process by which applications will be assessed for fit to the program, and key review criteria that should be kept in mind during application preparation.

Topic: NIGMS Technology Development Webinar

Time: May 14, 2019 3:00 - 4:00 PM Eastern Time (US and Canada)

Join the Zoom Meeting

Password: NIGMS

Meeting ID: 376 708 758

One tap mobile

+16465588656,,376708758# US (New York)

+16699006833,,376708758# US (San Jose)

Dial by your location

+1 646 558 8656 US (New York)

+1 669 900 6833 US (San Jose)

877 369 0926 US Toll-free

877 853 5247 US Toll-free

Find your local number

Slides will be posted on the Technology development website.

Questions can be submitted in advance or during the webinar to:


Please direct all inquiries to:

Paul Sammak, Ph.D.
Division of Biomedical Technology, Bioinformatics, and Computational Biosciences
National Institute of General Medical Sciences (NIGMS)


Miles Fabian, Ph.D.
Division of Pharmacology, Physiology, and Biological Chemistry
National Institute of General Medical Sciences (NIGMS)